Evaluation of Combination Treatment Benefits of nab-Paclitaxel in Experimental Pancreatic Cancer

被引：0
|
作者：
Awasthi, N. [1 ]
Ostapoff, K. T. [1 ]
Zhang, C. [1 ]
Schwarz, M. A. [1 ]
Schwarz, R. E. [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S153 / S153
页数：1
相关论文
共 50 条
  • [41] Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report
    Comito, Francesca
    Grassi, Elisa
    Poerio, Antonio
    Freier, Eva
    Calculli, Lucia
    Zompatori, Maurizio
    Ricci, Claudio
    Casadei, Riccardo
    Di Marco, Mariacristina
    BJR CASE REPORTS, 2018, 4 (02):
  • [42] Nab-paclitaxel in combination with gemcitabine for the treatment of metastatic pancreas cancer: the South Wales experience
    Quinton, A. E.
    Gwynne, S. H.
    Yim, K. L.
    MEDICAL ONCOLOGY, 2018, 35 (08)
  • [43] Nab-paclitaxel in combination with gemcitabine for the treatment of metastatic pancreas cancer: the South Wales experience
    A. E. Quinton
    S. H. Gwynne
    K. L. Yim
    Medical Oncology, 2018, 35
  • [44] nab-Paclitaxel for the Treatment of Aggressive Metastatic Breast Cancer
    Glueck, Stefan
    CLINICAL BREAST CANCER, 2014, 14 (04) : 221 - 227
  • [45] Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites
    Inoue, Kanae
    Fukushi, Koh
    Yamaguchi, Shota
    Taira, Tomonao
    Shibuki, Taro
    Satake, Tomoyuki
    Watanabe, Kazuo
    Sasaki, Mitsuhito
    Imaoka, Hiroshi
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    PANCREATOLOGY, 2024, 24 (04) : 616 - 623
  • [46] Biweekly Gemcitabine/Nab-Paclitaxel as First-line Treatment for Advanced Pancreatic Cancer
    Kokkali, Stefania
    Tripodaki, Elli-Sophia
    Drizou, Maria
    Stefanou, Dimitra
    Magou, Elpida
    Zylis, Dimosthenis
    Kapiris, Matthaios
    Nasi, Despoina
    Georganta, Chara
    Ardavanis, Alexandros
    IN VIVO, 2018, 32 (03): : 653 - 657
  • [47] Nab-Paclitaxel Monotherapy in Refractory Pancreatic Adenocarcinoma
    Peddi, P. F.
    Wang, J.
    Wang-Gillam, A.
    PANCREAS, 2012, 41 (08) : 1395 - 1395
  • [48] Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma
    Peddi, Parvin F.
    Cho, May
    Wang, Jian
    Gao, Feng
    Wang-Gillam, Andrea
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (04) : 370 - 373
  • [49] Efficacy and safety of the TH-302, gemcitabine, and nab-paclitaxel combination in xenograft models of pancreatic cancer
    Sun, Jessica D.
    Liu, Qian
    Ahluwalia, Dharmendra
    Li, Wenwu
    Wang, Yan
    Ruprell, Ayesha S.
    Hart, Charles P.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [50] The retrospective analysis of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer
    Ueno, M.
    Kobayashi, S.
    Ohkawa, S.
    Tezuka, S.
    Moriya, S.
    Morimoto, M.
    ANNALS OF ONCOLOGY, 2015, 26 : 67 - 67
12345